EA200801847A1 - ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ - Google Patents

ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ

Info

Publication number
EA200801847A1
EA200801847A1 EA200801847A EA200801847A EA200801847A1 EA 200801847 A1 EA200801847 A1 EA 200801847A1 EA 200801847 A EA200801847 A EA 200801847A EA 200801847 A EA200801847 A EA 200801847A EA 200801847 A1 EA200801847 A1 EA 200801847A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cancer
capcna
peptide inhibition
interaction
capcna interaction
Prior art date
Application number
EA200801847A
Other languages
English (en)
Russian (ru)
Inventor
Роберт Дж. Хикки
Линда Х. Малкас
Original Assignee
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн filed Critical Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн
Publication of EA200801847A1 publication Critical patent/EA200801847A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EA200801847A 2006-02-17 2007-02-16 ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ EA200801847A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74331306P 2006-02-17 2006-02-17
PCT/US2007/062335 WO2007098415A2 (en) 2006-02-17 2007-02-16 Peptide based inhibition of capcna protein-protein interactions in cancer

Publications (1)

Publication Number Publication Date
EA200801847A1 true EA200801847A1 (ru) 2009-02-27

Family

ID=38235155

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801847A EA200801847A1 (ru) 2006-02-17 2007-02-16 ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ

Country Status (9)

Country Link
US (3) US8653039B2 (cg-RX-API-DMAC7.html)
EP (1) EP1989225A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009527498A (cg-RX-API-DMAC7.html)
CN (1) CN101384618A (cg-RX-API-DMAC7.html)
AU (1) AU2007217037A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0707948A2 (cg-RX-API-DMAC7.html)
CA (1) CA2638866C (cg-RX-API-DMAC7.html)
EA (1) EA200801847A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007098415A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200801847A1 (ru) * 2006-02-17 2009-02-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ
WO2008036929A2 (en) * 2006-09-21 2008-03-27 Alnylam Pharmaceuticals, Inc. Complex for transferring an anionic substance into a cell
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
CA2732737C (en) * 2008-07-24 2019-03-05 Indiana University Research And Technology Corporation Cancer peptide therapeutics
FR2942798B1 (fr) * 2009-03-05 2011-04-08 Centre Nat Rech Scient Peptides utilisables pour le traitement de la leucemie lymphoide chronique
WO2011044374A1 (en) * 2009-10-07 2011-04-14 Indiana University Research And Technology Corporation Capcna peptide therapeutics for cancer
EP2538959A1 (en) * 2010-02-24 2013-01-02 Institut National de la Santé et de la Recherche Médicale Compounds for the treatment of inflammation and neutropenia
JP2013522613A (ja) * 2010-03-18 2013-06-13 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 化学療法に対する応答性を予測するための方法
US9475840B2 (en) 2012-02-27 2016-10-25 Universitat De Barcelona Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs
GB201214007D0 (en) * 2012-08-07 2012-09-19 Scancell Ltd Anti-tumour immune responses to modified self-epitopes
US10420840B2 (en) * 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents
JP2020514256A (ja) * 2016-12-15 2020-05-21 ザ ナショナル インスティチュート フォー バイオテクノロジー イン ザ ネゲヴ,リミテッド 抗pcnaモノクローナル抗体及びその使用
GB201815041D0 (en) 2018-09-14 2018-10-31 Scancell Ltd Epitopes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935797A (en) 1994-06-16 1999-08-10 Stanford University Interaction of MHC Class II proteins with members of the PCNA family of proteins
GB9509557D0 (en) * 1995-05-11 1995-07-05 Univ Dundee PCNA binding substance
JP2002518341A (ja) * 1998-06-15 2002-06-25 アーチ・デヴェロップメント・コーポレイション 放射線療法と抗血管形成因子の組み合わせ
US7294471B2 (en) 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen
MX2007013584A (es) 2005-04-27 2008-04-22 Univ Indiana Res & Tech Corp Anticuerpos de isoforma de cspcna y sus usos.
DE602006021178D1 (de) 2005-06-27 2011-05-19 Univ Indiana Res & Tech Corp Cspcna-isoform-modifikationen und anwendungen davon
EA200801847A1 (ru) * 2006-02-17 2009-02-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ

Also Published As

Publication number Publication date
US9187526B2 (en) 2015-11-17
EP1989225A2 (en) 2008-11-12
CN101384618A (zh) 2009-03-11
BRPI0707948A2 (pt) 2011-05-17
US20140296156A1 (en) 2014-10-02
US20090232882A1 (en) 2009-09-17
CA2638866A1 (en) 2007-08-30
US20160304559A1 (en) 2016-10-20
WO2007098415A3 (en) 2007-12-13
US8653039B2 (en) 2014-02-18
AU2007217037A1 (en) 2007-08-30
WO2007098415A2 (en) 2007-08-30
CA2638866C (en) 2015-11-10
JP2009527498A (ja) 2009-07-30

Similar Documents

Publication Publication Date Title
WO2007098415A3 (en) Peptide based inhibition of capcna protein-protein interactions in cancer
EP2536821A4 (en) IMPROVING THE EFFECT OF FE-S-BUNDLE REQUIRING PROTEINS
CL2011000086A1 (es) Anticuerpo aislado o proteina funcional contra el polipeptido baffr que inhibe la proliferacion de celulas b; secuencia nucleotidicas de dicho anticuerpo; vector y celula huesped que comprende dicha secuencia; y su uso para tratar enfermedades autoinmunes o neoplasias de celulas b.
EA201690377A1 (ru) Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения
WO2010011890A3 (en) Cancer peptide therapeutics
EA202090805A1 (ru) Клетки для получения рекомбинантной идуронат-2-сульфатазы
AU2010220421A8 (en) Antibodies against a proliferating inducing ligand (APRIL)
NZ595707A (en) Cancer antigen helper peptide
MX351502B (es) Anticuerpos de union de albumina y fragmentos de union de los mismos.
EA200800229A1 (ru) Человеческие моноклональные антитела против лиганда-1 запрограммированной гибели клеток (pd-l1)
EA201301180A1 (ru) Основанная на bcma стратификация и терапия пациентов, страдающих множественной миеломой
CA2848209C (en) T cell receptors recognizing hla-a1- or hla-cw7-restricted mage
AR068553A1 (es) Vacunas y componentes de vacuna para la inhibicion de celulas microbianas
EA201100779A1 (ru) Композиции антител к cxcr1 и способы их применения
ECSP099341A (es) Nuevos anticuerpos antiproliferativos
AU2011353197A8 (en) A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis
NO20081987L (no) Humane, monoklonale antistoffer mot CD70
MX2014005108A (es) Constructos de polipeptidos y sus usos.
MX384246B (es) POLIPÉPTIDO DE UNIÓN A TCR ALFA BETA PARA USARSE EN LA DISMINUCIÓN DE LINFOCITOS TAß.
CY1121466T1 (el) Αντισωματα εναντι προσδεματων υποδοχεα β1 βραδυκινινης
MX348152B (es) Anticuerpo monoclonal humano con especificidad para el virus del dengue serotipo 1 proteina e y sus usos.
NZ601582A (en) Agonist dr5 binding polypeptides
EA201991409A3 (ru) Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения
ATE404225T1 (de) Radiofluorierte peptide
IL189452A0 (en) Therapy with cd4 binding peptides and radiation